General issues related to hospitals and healthcare in COVID-19 response efforts; antitrust; drug pricing; privacy; physician-owned hospitals; cybersecurity; H.R. 4366, the Consolidated Appropriations Act 2024; and H.R. 2882, the Further Consolidated Appropriations Act 2024
General issues related to hospitals and healthcare in COVID-19 response efforts; the Provider Relief Fund; antitrust; drug pricing and 340B Drug Pricing Program; Medicare for All and the public option; site-neutral payments; Disproportionate Share Hospital (DSH) payments; cybersecurity; H.R. 4366, the Consolidated Appropriations Act 2024; and H.R. 2882, the Further Consolidated Appropriations Act 2024
General issues related to hospitals and healthcare in COVID-19 response efforts and drug pricing; H.R. 4366, the Consolidated Appropriations Act 2024; and H.R. 2882, the Further Consolidated Appropriations Act 2024
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel including S. 2768/H.R.2584, the SAVE Act.
Duration: May 1, 2017
to
present
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Labor Issues/Antitrust/Workplace , Taxation/Internal Revenue Code , Immigration , Telecommunications
Spending: about $1,660,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives, Executive Office of the President (EOP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
David Leiter
Legislative Assistant, U.S. Senator Wendell Ford
Chief of Staff, U.S. Senator John Kerry
Principal Deputy Assistant Secretary for Energy Efficiency and Renewable Energy, U.S. Department of Energy
Sarah Litke
n/a
Georgette Spanjich
n/a
Jean Cornell
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on April 17.
Original Filing: 301552531.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; antitrust; drug pricing; privacy; physician-owned hospitals; cybersecurity; H.R. 4366, the Consolidated Appropriations Act 2024; and H.R. 2882, the Further Consolidated Appropriations Act 2024
Agencies Lobbied
U.S. Senate U.S. House of Representatives Executive Office of the President (EOP)
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; the Provider Relief Fund; antitrust; drug pricing and 340B Drug Pricing Program; Medicare for All and the public option; site-neutral payments; Disproportionate Share Hospital (DSH) payments; cybersecurity; H.R. 4366, the Consolidated Appropriations Act 2024; and H.R. 2882, the Further Consolidated Appropriations Act 2024
Agencies Lobbied
U.S. Senate U.S. House of Representatives Executive Office of the President (EOP)
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts and drug pricing; H.R. 4366, the Consolidated Appropriations Act 2024; and H.R. 2882, the Further Consolidated Appropriations Act 2024
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel including S. 2768/H.R.2584, the SAVE Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2023
In Q4, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Jan. 19.
Original Filing: 301531633.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; antitrust; drug pricing; privacy; physician-owned hospitals; S.2840, the Bipartisan Primary Care and Health Workforce Act; S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023; and H.R.5378, the Lower Costs, More Transparency Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; the Provider Relief Fund; antitrust; drug pricing and 340B Drug Pricing Program; Medicare for All and the public option; site-neutral payments; Inpatient Prospective Payment System (IPPS); Disproportionate Share Hospital (DSH) payments; S.1869, the SITE Act; S.2840, the Bipartisan Primary Care and Health Workforce Act; S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023; and H.R.5378, the Lower Costs, More Transparency Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts and drug pricing
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel including S. 2768/H.R.2584, the SAVE Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2023
In Q3, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Oct. 19, 2023.
Original Filing: 301508314.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; the Provider Relief Fund; antitrust; drug pricing: privacy; physician-owned hospitals; S.2333, the Pandemic and All-Hazards Preparedness and Response Act; S.2840, Bipartisan Primary Care and Health Workforce Act; H.R.4420, Preparedness and Response Reauthorization Act; H.R.4421, the Preparing for All Hazards and Pathogens Reauthorization Act; and H.R.5378, the Lower Costs, More Transparency Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; the Provider Relief Fund; antitrust; drug pricing and 340B Drug Pricing Program; Medicare for All and the public option; site-neutral payments; Inpatient Prospective Payment System (IPPS); Disproportionate Share Hospital (DSH) payments; S.1869, the SITE Act; S.2840, Bipartisan Primary Care and Health Workforce Act; H.R.2863, the Preventing Hospital Overbilling of Medicare Act; and H.R.5378, the Lower Costs, More Transparency Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts and drug pricing
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel including S. 2768 and H.R.2584, the SAVE Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2023
In Q2, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on July 19, 2023.
Original Filing: 301483729.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, the Provider Relief Fund, antitrust, drug pricing, privacy, physician-owned hospitals, and Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; the Provider Relief Fund; antitrust; drug pricing and 340B Drug Pricing Program; Medicare for All and the public option; site-neutral payments; Inpatient Prospective Payment System (IPPS); Disproportionate Share Hospital (DSH) payments; H.R.2863, the Preventing Hospital Overbilling of Medicare Act; and S.1869, the SITE Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, and drug pricing
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel including H.R.2584, the SAVE Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2023
In Q1, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on April 18, 2023.
Original Filing: 301454590.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, the Provider Relief Fund, antitrust, and drug pricing
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, the Provider Relief Fund, antitrust, drug pricing, and Medicare for All and the public option
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, and drug pricing
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2022
In Q4, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Jan. 13, 2023.
Original Filing: 301427136.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester and Statutory Pay-As-You Go (PAYGO) sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals, including Medicare-dependent Hospital (MDH) and enhanced Low-volume Hospital (LVH) programs; issues related to the Affordable Care Act (ACA); issues related to healthcare in H.R. 2617, the Consolidated Appropriations Act of 2023; issues related to the Provider Relief Fund; issues related to implementation of the Consolidated Appropriations Act of 2021 (No Surprises Act); and issues related to antitrust
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester and Statutory Pay-As-You Go (PAYGO) sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals, including Medicare-dependent Hospital (MDH) and enhanced Low-volume Hospital (LVH) programs; issues related to the Affordable Care Act (ACA); issues related to Medicare for All and the public option; and issues related to healthcare in H.R. 2617, the Consolidated Appropriations Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues in H.R. 2471, the Consolidated Appropriations Act, 2022, to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to 340B eligibility due to a drop in disproportionate share hospitals (DSH) adjustment percentages; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester and Statutory Pay-As-You Go (PAYGO) sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; and issues related to healthcare in H.R. 2617, the Consolidated Appropriations Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel, including H.R. 7961, the SAVE Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2022
In Q3, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Oct. 14, 2022.
Original Filing: 301404172.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act, and H.R. 5376, the Inflation Reduction Act of 2022; issues related to the Medicare sequester and Statutory Pay-As-You Go (PAYGO) sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals, including Medicare-dependent Hospital (MDH) and enhanced Low-volume Hospital (LVH) programs; issues related to the Affordable Care Act (ACA); issues related to healthcare in H.R. 6833, the Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023; issues related to the Provider Relief Fund; issues related to implementation of Consolidated Appropriations Act of 2021 (No Surprises Act); and issues related to antitrust
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester and Statutory Pay-As-You Go (PAYGO) sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals, including Medicare-dependent Hospital (MDH) and enhanced Low-volume Hospital (LVH) programs; issues related to the Affordable Care Act (ACA); issues related to Medicare for All and the public option; and issues related to healthcare in H.R. 6833, the Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues in H.R. 2471, the Consolidated Appropriations Act, 2022, to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to 340B eligibility due to a drop in disproportionate share hospitals (DSH) adjustment percentages; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester and Statutory Pay-As-You Go (PAYGO) sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; and issues related to healthcare in H.R. 6833, the Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel, including H.R. 7961, the SAVE Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2022
In Q2, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on July 15, 2022.
Original Filing: 301380948.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to healthcare in H.R. 5376, the Build Back Better Act; issues related to the Provider Relief Fund; and issues related to implementation of Consolidated Appropriations Act of 2021 (No Surprises Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to Medicare for All and the public option; and issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues in H.R. 2471, the Consolidated Appropriations Act, 2022, to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to 340B eligibility due to a drop in disproportionate share hospitals (DSH) adjustment percentages; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; and issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to violence against hospital personnel, including H.R. 7961, the SAVE Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2022
In Q1, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on April 18, 2022.
Original Filing: 301358257.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to healthcare in H.R. 5376, the Build Back Better Act; issues related to the Provider Relief Fund; and issues related to implementation of Consolidated Appropriations Act of 2021 (No Surprises Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to Medicare for All and the public option; and issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues in H.R. 2471, the Consolidated Appropriations Act, 2022, to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to 340B eligibility due to a drop in disproportionate share hospitals (DSH) adjustment percentages; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; and issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2021
In Q4, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Jan. 17, 2022.
Original Filing: 301323919.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, an Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to healthcare in H.R. 5376, the Build Back Better Act; issues related to the Provider Relief Fund; and issues related to implementation of Consolidated Appropriations Act of 2021 (No Surprises Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to Medicare for All and the public option; and issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY22 appropriations to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; and issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to healthcare in H.R. 5376, the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
3rd Quarter, 2021
In Q3, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Oct. 18, 2021.
Original Filing: 301301264.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to healthcare in the Build Back Better Act; and issues related to the Provider Relief Fund
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); issues related to Medicare for All and the public option; and issues related to healthcare in the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY22 appropriations to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; and issues related to healthcare in the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections, and general issues related to healthcare in the Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2021
In Q2, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on July 16, 2021.
Original Filing: 301278276.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; and issues related to the Affordable Care Act (ACA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); and issues related to Medicare for All and the public option
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY22 appropriations to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; and issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2021
In Q1, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on April 16, 2021.
Original Filing: 301254206.xml
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including H.R. 1319, the American Rescue Plan Act; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; and issues related to the Affordable Care Act (ACA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including H.R. 1319, the American Rescue Plan Act; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes; issues related to rural hospitals; issues related to the Affordable Care Act (ACA); and issues related to Medicare for All and the public option
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY22 appropriations to prevent or minimize hospital cuts; issues related to hospitals and healthcare in COVID-19 response efforts, including H.R. 1319, the American Rescue Plan Act; issues related to drug pricing, including H.R. 3, the Lower Drug Costs Now Act; and issues related to the Medicare sequester, including H.R. 1868, An Act to prevent across-the-board direct spending cuts, and for other purposes
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to hospitals and healthcare in COVID-19 response efforts, including OSHA workplace protections
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
4th Quarter, 2020
In Q4, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233145.xml
Lobbying Issues
General issues related to drug pricing, including surprise medical bills and related legislation, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act, as well as S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to the Affordable Care Act (ACA); and issues related to healthcare extenders
Lobbying Issues
General issues related to Medicare for All; issues related to 340b, drug pricing, and price transparency policies, including S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to surprise medical bills, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to the Affordable Care Act (ACA); issues related to the Medicaid disproportionate share hospital (DSH) cuts
Lobbying Issues
General issues related to FY21 appropriations to prevent or minimize hospital cuts; issues related to COVID-19 response efforts; and issues related to healthcare extenders
Lobbying Issues
General issues related to healthcare extenders and COVID-19 response efforts
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2020
In Q3, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Oct. 16, 2020.
Original Filing: 301211140.xml
Lobbying Issues
General issues related to drug pricing, including surprise medical bills and related legislation, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act, as well as S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to the Affordable Care Act (ACA); and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to Medicare for All; issues related to 340b, drug pricing, and price transparency policies, including S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to surprise medical bills, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to the Affordable Care Act (ACA); issues related to the Medicaid disproportionate share hospital (DSH) cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY21 appropriations to prevent or minimize hospital cuts; issues related to COVID-19 response efforts; and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to healthcare extenders and COVID-19 response efforts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2020
In Q2, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on July 17, 2020.
Original Filing: 301191093.xml
Lobbying Issues
General issues related to drug pricing, including surprise medical bills and related legislation, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act, as well as S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to hospitals and healthcare in COVID-19 response efforts, including H.R. 748, the CARES Act; issues related to the Affordable Care Act (ACA); and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to Medicare for All; issues related to 340b, drug pricing, and price transparency policies, including S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to surprise medical bills, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act; issues related to hospitals and healthcare in COVID-19 response efforts, including H.R. 748, the CARES Act; issues related to the Affordable Care Act (ACA); issues related to the Medicaid disproportionate share hospital (DSH) cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY21 appropriations to prevent or minimize hospital cuts and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to healthcare extenders and COVID-19 response efforts, including H.R. 748, the CARES Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2020
In Q1, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on April 15, 2020.
Original Filing: 301166967.xml
Lobbying Issues
General issues related to drug pricing, including surprise medical bills and related legislation, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act, as well as S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to the Affordable Care Act; and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to Medicare for All; issues related to 340b, drug pricing, and price transparency policies, including S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to surprise medical bills, including H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, H.R. 3630, the No Surprises Act, and H.R. 5800, the Ban Surprise Billing Act; issues related to hospitals and healthcare in COVID-19 response efforts; issues related to the Affordable Care Act; issues related to the Medicaid disproportionate share hospital (DSH) cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY21 appropriations to prevent or minimize hospital cuts and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to healthcare extenders, including the May 22 deadline, as well COVID-19 response efforts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2019
In Q4, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108451.xml
Lobbying Issues
General issues related to drug pricing, including surprise medical bills and S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to the Affordable Care Act; and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to Medicare for All; issues related to 340b, drug pricing, and price transparency policies, including S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to the Affordable Care Act; issues related to the Medicaid disproportionate share hospital (DSH) cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY20 appropriations to prevent or minimize hospital cuts and issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to healthcare extenders
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2019
In Q3, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Oct. 16, 2019.
Original Filing: 301066493.xml
Lobbying Issues
General issues related to drug pricing, including surprise medical bills and S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; and issues related to the Affordable Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to Medicare for All; issues related to 340b, drug pricing, and price transparency policies, including S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to the Affordable Care Act; issues related to the Medicaid disproportionate share hospital (DSH) cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY20 appropriations to prevent or minimize hospital cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on July 15, 2019.
Original Filing: 301045942.xml
Lobbying Issues
General issues related to drug pricing, including surprise medical bills and S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; and issues related to the Affordable Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to Medicare for All; issues related to 340b, drug pricing, and price transparency policies, including S. 1895, the Lower Health Care Costs Act; issues related to rural hospitals; issues related to the Affordable Care Act; issues related to the Medicaid disproportionate share hospital (DSH) cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General issues related to FY20 appropriations to prevent or minimize hospital cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on April 15, 2019.
Original Filing: 301025166.xml
Lobbying Issues
General issues related to federal health policies
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
General Issues related to federal health policies
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006693.xml
Lobbying Issues
General issues related to federal health policies
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
General issues related to immigration requirements for foreign educated nurses
3rd Quarter, 2018
In Q3, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Oct. 18, 2018.
Original Filing: 300988205.xml
Lobbying Issues
General issues related to federal health policies
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2018
In Q2, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on July 18, 2018.
Original Filing: 300967927.xml
Lobbying Issues
General issues related to federal health policies
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
General issues related to rural broadband access for health care providers
1st Quarter, 2018
In Q1, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on April 17, 2018.
Original Filing: 300946169.xml
Lobbying Issues
General issues related to federal health policies
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
General issues related to hospitals
4th Quarter, 2017
In Q4, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Jan. 17, 2018.
Original Filing: 300925064.xml
Lobbying Issues
General issues related to federal health policies
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
General issues related to hospitals
Lobbying Issues
General issues related to federal health policies in tax reform
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $60,000. The report was filed on Oct. 18, 2017.
Original Filing: 300907384.xml
Lobbying Issues
General issues related to federal health policies
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2017
PLURUS STRATEGIES, LLC amended a lobbying report for representation of American Hospital Association in Q22017 on July 20, 2017.
Original Filing: 300892210.xml
Lobbying Issues
General issues related to federal health policies
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2017
In Q2, PLURUS STRATEGIES, LLC lobbied for American Hospital Association , earning $40,000. The report was filed on July 19, 2017.
Original Filing: 300888830.xml
Lobbying Issues
General issues related to federal health policies
Type of Issue
Health Issues Medicare/Medicaid
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate